AlphAIAlphAI — Financial news for AI agents
yahoo.comAUG 292 min read

Key Tronic Corporation Q4 2026 Earnings Call Summary

Key Tronic Corporation reported Q4 2026 earnings impacted by $28.4M non-cash valuation allowance and $8.4M receivables write-off. Revenue rose 14% sequentially, driven by Vietnam demand. Management shifted production from China to U.S. and Vietnam, improving margins to 8.3%. The company expects revenue growth and profitability in fiscal 2027, supported by a $60M new program award. Liquidity constraints and supply chain pressures were noted.

Original reporting
yahoo.com
Published Aug 29, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 29, 2026, 3:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Key Tronic Corporation Q4 2026 Earnings Call Summary — source image
Source · yahoo.com
Decision brief

The 30-second read

Med
01

Why it matters

Earnings beat and new contract provide a catalyst for short‑term price appreciation, though liquidity constraints remain a risk.

02

Market read

First‑time disclosure of earnings, guidance, and a $60M contract makes this a material news event for traders.

03

What to watch

Potential cash‑flow constraints from delayed shipments and tightened supplier credit may pressure near‑term earnings.

Relevance 7/10Novelty 7/10Timing: post‑earnings Q4 2026 release

Background

Key Tronic reported Q4 2026 results, detailing operational changes, tax adjustments, and a new $60M program award.

Market effects

Sector

Highlights resilience in contract manufacturing amid supply‑chain shifts, may benefit peers in the electronics manufacturing services sector.

Regional

U.S. and Vietnam manufacturing outlook improves; China exit could affect regional supplier dynamics.

Global

Shows how geopolitical risk management can create upside for small‑cap manufacturers.

Counterpoint

What could challenge this read

The $28.4M tax allowance and $8.4M receivable write‑off signal lingering liquidity stress that could limit upside.

Key entities

  • company
    Key Tronic Corporation

    U.S. contract manufacturer reporting Q4 2026 earnings.

Read at source← All news

Related articles

AUG 28
$KTCCMed

Key Tronic Corporation Announces Results for the Fourth Quarter and Year End of Fiscal 2026 · EMSNow

Key Tronic Corporation (KTCC) reported Q4 2026 revenue of $102.0M, up 14% sequentially, driven by strong demand. Full-year revenue was $386.7M, down from $467.9M in 2025. Gross margin improved to 7.8% from 6.2%. The company faced supply chain constraints and reported a net loss of $34.3M for the quarter. Management highlighted new program wins and cost-cutting initiatives.

emsnow.com2 min
AUG 27
$KTCCMed

KEY TRONIC CORP (KTCC): Results of Operations and Financial Condition

KEY TRONIC CORP (KTCC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE CONTACTS: Tony Voorhees Michael Newman Chief Financial Officer Investor Relations Key Tronic Corporation StreetConnect (509)-927-5345 (206) 729-3625 KEY TRONIC CORPORATION ANNOUNCES RESULTS FOR THE FOURTH QUARTER AND YEAR END OF FISCAL 2026 Stro

SEC EDGAR 8-K2 min
SEP 22
$AZOMedAI 8/10

AutoZone Q4 EPS Hits $56.05 as Annual Sales Reach $20.3bn

AutoZone (AZO) reported Q4 2026 EPS of $56.05, up from $48.71 a year earlier, with net sales of $6.6bn, a 5.6% increase. Full-year sales reached $20.3bn, up 7.4%. Gross margin rose to 53.3%, boosted by tariff refunds and LIFO benefits. The company opened 175 new stores, ending the year with 8,031 locations. Shares rose 4.33% post-earnings.

financial-news.co.uk2 min
SEP 22
$AZOHighAI 8/10

Why AutoZone (AZO) Stock Is Trading Up Today

AutoZone (AZO) shares rose 6.1% after reporting Q4 EPS of $56.05, beating estimates. Net sales were $6.6B, missing expectations. Same-store sales grew 1.6%, and gross margin expanded 182 bps to 53.3%. The company's stock has had limited volatility, with today's move being notable. AZO is down 9.9% YTD, trading 30.6% below its 52-week high.

financialcontent.com2 min
SEP 22
$AMGNMedAI 8/10

Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data - Amgen (NA

Amgen (AMGN) reported positive results from its Phase 3 OASIZ 301 trial for dazodalibep in treating Sjögren’s disease, meeting the primary endpoint. The study showed statistically significant improvements in disease activity scores. Adverse events were low and similar to placebo. Amgen plans to share full data at a future conference and awaits results from another trial, OASIZ 303, for potential FDA filing. Shares rose 3.54% to $407.08. Analysts expect two positive trials for approval.

benzinga.com4 min